Al Mayadeen English

  • Ar
  • Es
  • x
Al Mayadeen English

Slogan

  • News
    • Politics
    • Economy
    • Sports
    • Arts&Culture
    • Health
    • Miscellaneous
    • Technology
    • Environment
  • Articles
    • Opinion
    • Analysis
    • Blog
    • Features
  • Videos
    • NewsFeed
    • Video Features
    • Explainers
    • TV
    • Digital Series
  • Infographs
  • In Pictures
  • • LIVE
News
  • Politics
  • Economy
  • Sports
  • Arts&Culture
  • Health
  • Miscellaneous
  • Technology
  • Environment
Articles
  • Opinion
  • Analysis
  • Blog
  • Features
Videos
  • NewsFeed
  • Video Features
  • Explainers
  • TV
  • Digital Series
Infographs
In Pictures
  • Africa
  • Asia
  • Asia-Pacific
  • Europe
  • Latin America
  • MENA
  • Palestine
  • US & Canada
BREAKING
Sheikh Qassem: Our supporters make up more than half of Lebanon's population, and all of these people are united under the banner of protecting Lebanon, its Resistance, its people, and its integrity.
Sheikh Qassem: There will be no phased handing in of our arms. [The Israelis] must first enact the agreement before we start talking about a defensive strategy.
Sheikh Qassem: Be brave in the face of foreign pressures, and we will be by your side in this stance.
Sheikh Qassem: Stripping us of our arms is like stripping us of our very soul, and this will prompt us to show them our might.
Sheikh Qassem: We will not abandon our arms, for they gave us dignity; we will not abandon our arms, for they protect us against our enemy.
Sheikh Qassem: The US efforts we are seeing are aimed at sabotaging Lebanon and constitute a call for sedition.
Sheikh Qassem: If you truly want to establish sovereignty and work for Lebanon’s interests, then stop the aggression.
Sheikh Qassem: The United States, which is meddling in Lebanon, is not trustworthy but rather poses a danger to it.
Sheikh Qassem: The United States is preventing the weapons that protect the homeland.
Sheikh Qassem: The government’s latest decision [on the disarmament of the Resistance] is non-charter-based, and if the government continues down this path, it is not faithful to Lebanon’s sovereignty.

‘Breakthrough’ drugs shrink tumors in half ovarian cancer patients

  • By Al Mayadeen English
  • Source: Agencies
  • 4 Jun 2023 13:21
2 Min Read

The groundbreaking therapy has been found to drastically prevent tumor development, allowing the illness to be kept at bay for years.

  • x
  • An intern at the Hampton University Cancer Research Centre in Virginia, the US, examines cancer cells. (AP)
    An intern at the Hampton University Cancer Research Centre in the US examining cancer cells (AP)

Thousands of women with ovarian cancer may benefit from a groundbreaking medicine combination that has been demonstrated to considerably decrease tumors in nearly half of patients with the condition.

The new medication inhibits tumor development, which can help put the cancer at bay for years. The "fantastic" and "very exciting" findings of clinical trials of the medicine combination, presented this weekend at the world's largest cancer conference, revealed it was "far more effective" than any other existing alternative for patients, as per experts.

The Royal Marsden NHS Foundation Trust and the Institute of Cancer Research in London conducted a phase 2 study on 29 patients to evaluate the medicine Avutometinib alone and in combination with Defactinib.

According to trial data, over half of the patients on the new medicine combination had their tumors shrink considerably. It was nearly twice as successful as the next best therapy, trametinib, which had a 26% response rate.

Patients with a specific mutation had even better results, with 60% of KRAS-driven ovarian tumors shrinking following therapy.

However, nearly a third of patients (29%) who did not have the mutation had an optimistic response, which is an improvement over usual therapy.

All of the patients had low-grade serous ovarian cancer, which is more common in young women.

Dr. Susana Banerjee, the global lead investigator of the study presented at the American Society of Clinical Oncology’s annual meeting in Chicago, affirmed that the new drug could represent a “significant breakthrough”.

“These initial results could be fantastic news for women with low-grade serous ovarian cancer, indicating a far more effective option than current treatments,” she said.

It is worth noting that Avutometinib is a dual RAF and MEK inhibitor, which is a sort of targeted medicine that inhibits specific proteins that aid in cancer development and survival. According to research, the medicine might become ineffective over time as tumors acquire treatment resistance.

However, when paired with Defactinib, which combats a protein that promotes treatment resistance, Avutometinib performs better. The medication combination outperforms Avutometinib alone by a factor of four.

Read next: New cancer treatment offers hope to patients out of options

  • defactinib
  • Cancer
  • Avutometinib
  • ovarian cancer

Most Read

Tom Artiom Alexandrovich, executive director of the defense division of the Israeli National Cyber Directorate, undated (Social media)

Israeli-born US prosecutor drops Israeli officer child sex crime

  • Politics
  • 19 Aug 2025
Almost instantly after the Helsinki Accords were signed, organisations sprouted to document purported violations, whose findings were fed to overseas embassies for international amplification. (Al Mayadeen English; Illustrated by Zeinab el-Hajj)

How ‘Human Rights’ became a Western weapon

  • Opinion
  • 23 Aug 2025
Israeli soldiers stand on the top of armoured vehicles parked on an area near the Israeli-Gaza border, as seen from southern Israel, Wednesday, Aug. 20, 2025 (AP)

Palestinian fighters target Israeli soldiers, vehicles in Gaza

  • Politics
  • 21 Aug 2025
Launch of a ballistic missile from Yemen toward the occupied Palestinian territories. (YAF military media)

Yemeni Forces announce firing hypersonic missile at Al-Lydd Airport

  • Politics
  • 22 Aug 2025

Coverage

All
The Ummah's Martyrs

Read Next

All
Israeli Prime Minister Benjamin Netanyahu speaks during a press conference at the Prime minister's office in al-Quds, Occupied Palestine, Sunday, Aug. 10, 2025 (AP)
Politics

Netanyahu deliberately derailing truce with Gaza occupation: Hamas

Irish President Michael Higgins arrives to deliver his speech during a 42nd World Food Day celebration at FAO headquarters in Rome, on Oct. 16, 2023. (AP Photo/Alessandra Tarantino)
Politics

Irish president renews call for UN military intervention in Gaza

US Ambassador to Turkey and Special Envoy to Syria Tom Barrack speaks during an interview with The Associated Press at the US Embassy in Aukar, northern suburb of Beirut, Lebanon, Monday, July 21, 2025 (AP)
Politics

US envoy, Netanyahu discuss restraining attacks on Lebanon, withdrawal

Smoke billows following Israeli airstrikes in multiple areas in Sanaa, Yemen, Sunday, Aug. 24, 2025 (AP)
Politics

Ansar Allah vow sustained Gaza support despite Israeli strikes

Al Mayadeen English

Al Mayadeen is an Arab Independent Media Satellite Channel.

All Rights Reserved

  • x
  • Privacy Policy
  • About Us
  • Contact Us
  • Authors
Android
iOS